Literature DB >> 20151849

Advances with the use of bio-inspired vectors towards creation of artificial viruses.

Helen O McCarthy1, Yuhua Wang, Sriramchandra S Mangipudi, Arash Hatefi.   

Abstract

IMPORTANCE OF THE FIELD: In recent years, there has been a great deal of interest in the development of recombinant vectors based on biological motifs with potential applications in gene therapy. Several such vectors have been genetically engineered, resulting in biomacromolecules with new properties that are not present in nature. AREAS COVERED IN THIS REVIEW: This review briefly discusses the advantages and disadvantages of the current state-of-the-art gene delivery systems (viral and non-viral) and then provides an overview on the application of various biological motifs in vector development for gene delivery. Finally, it highlights some of the most advanced bio-inspired vectors that are designed to perform several self-guided functions. WHAT THE READER WILL GAIN: This review helps the readers get a better understanding about the history and evolution of bio-inspired fusion vectors with the potential to merge the strengths of both viral and non-viral vectors in order to create efficient, safe and cost-effective gene delivery systems. TAKE HOME MESSAGE: With the emergence of new technologies such as recombinant bio-inspired vectors, it may not take long before non-viral vectors are observed that are not just safe and tissue-specific, but even more efficient than viral vectors.

Mesh:

Substances:

Year:  2010        PMID: 20151849     DOI: 10.1517/17425240903579989

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  12 in total

1.  Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus.

Authors:  Brenda F Canine; Yuhua Wang; Wenyun Ouyang; Arash Hatefi
Journal:  J Control Release       Date:  2010-12-28       Impact factor: 9.776

Review 2.  Progress and problems with the use of suicide genes for targeted cancer therapy.

Authors:  Zahra Karjoo; Xuguang Chen; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2015-05-22       Impact factor: 15.470

3.  Production of low-expressing recombinant cationic biopolymers with high purity.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Arash Hatefi
Journal:  Protein Expr Purif       Date:  2017-03-16       Impact factor: 1.650

4.  Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

Authors:  Arash Hatefi; Zahra Karjoo; Alireza Nomani
Journal:  Biomacromolecules       Date:  2017-08-24       Impact factor: 6.988

5.  Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; John W McBride; Cian M McCrudden; Eva M Vincente-Perez; Ryan F Donnelly; Helen O McCarthy
Journal:  Hum Vaccin Immunother       Date:  2016-11-15       Impact factor: 3.452

6.  Treatment of Rheumatoid Arthritis with Gene Therapy Applications: Biosafety and Bioethical Considerations.

Authors:  Zinovia Tsitrouli; Maria-Anna Akritidou; Savvas Genitsaris; Gijsbert van Willigen
Journal:  BioTech (Basel)       Date:  2021-06-23

Review 7.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

8.  HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.

Authors:  Yuhua Wang; Brenda F Canine; Arash Hatefi
Journal:  Nanomedicine       Date:  2010-10-01       Impact factor: 5.307

Review 9.  Microneedles: an innovative platform for gene delivery.

Authors:  Joanne McCaffrey; Ryan F Donnelly; Helen O McCarthy
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 5.671

10.  RALA-mediated delivery of FKBPL nucleic acid therapeutics.

Authors:  Rachel Bennett; Anita Yakkundi; Hayley D McKeen; Lana McClements; Thomas J McKeogh; Cian M McCrudden; Kenneth Arthur; Tracy Robson; Helen O McCarthy
Journal:  Nanomedicine (Lond)       Date:  2015-09-30       Impact factor: 6.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.